PT Inna Pharmaceutical Industry
↗Bogor, Indonesia
PT Inna Pharmaceutical Industry is an Indonesian pharmaceutical and cosmetic manufacturing company based in Gunung Putri, Bogor, West Java. Established in 2017, the company specializes in the production of semi-solid and liquid external medications and cosmetic products. They operate with a commitment to quality, holding certifications such as CPOB (Good Manufacturing Practice for Drugs) and CPKB (Good Manufacturing Practice for Cosmetics) issued by the Indonesian National Agency of Drug and Food Control (BPOM), as well as Halal Assurance System (HAS) certification from MUI.
The company provides end-to-end toll manufacturing services for pharmaceutical and cosmetic products. Their facility is equipped with modern machinery, including vacuum emulsification mixers, homogenizers, and automated filling and cartoning lines, designed to meet international standards for quality and affordability in the Southeast Asian market.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical and Cosmetic Manufacturing
SIZE & FINANCIALS
Employees:51-200
Founded:2017
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Semi-solid, Liquid
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:PT Meprofarm, PT Kimia Farma, PT Vitapharm
LINKS
Website:innapharma.co.id
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PT Inna Pharmaceutical Industry and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PT Inna Pharmaceutical Industry. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.